Global Geriatric Medicine Market Insights, Forecast to 2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Geriatric Medicine Revenue
• 1.4 Market by Type
  • 1.4.1 Global Geriatric Medicine Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Analgesics
  • 1.4.3 Antihypertensives
  • 1.4.4 Statins
  • 1.4.5 Antidiabetics
  • 1.4.6 Proton Pump Inhibitor
  • 1.4.7 Anticoagulant
  • 1.4.8 Antipsychotic
  • 1.4.9 Antidepressant
• 1.5 Market by Application
  • 1.5.1 Global Geriatric Medicine Market Share by Application: 2020 VS 2026
  • 1.5.2 Cardiovascular
  • 1.5.3 Arthritis
  • 1.5.4 Neurological
  • 1.5.5 Cancer
  • 1.5.6 Osteoporosis
  • 1.5.7 Respiratory
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Geriatric Medicine Market Perspective (2015-2026)
• 2.2 Global Geriatric Medicine Growth Trends by Regions
  • 2.2.1 Geriatric Medicine Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Geriatric Medicine Historic Market Share by Regions (2015-2020)
  • 2.2.3 Geriatric Medicine Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Geriatric Medicine Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Geriatric Medicine Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Geriatric Medicine Players by Market Size
  • 3.1.1 Global Top Geriatric Medicine Players by Revenue (2015-2020)
  • 3.1.2 Global Geriatric Medicine Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Geriatric Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Geriatric Medicine Market Concentration Ratio
  • 3.2.1 Global Geriatric Medicine Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Geriatric Medicine Revenue in 2019
• 3.3 Geriatric Medicine Key Players Head office and Area Served
• 3.4 Key Players Geriatric Medicine Product Solution and Service
• 3.5 Date of Enter into Geriatric Medicine Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Geriatric Medicine Historic Market Size by Type (2015-2020)
• 4.2 Global Geriatric Medicine Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Geriatric Medicine Market Size by Application (2015-2020)
• 5.2 Global Geriatric Medicine Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Geriatric Medicine Market Size (2015-2020)
• 6.2 Geriatric Medicine Key Players in North America (2019-2020)
• 6.3 North America Geriatric Medicine Market Size by Type (2015-2020)
• 6.4 North America Geriatric Medicine Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Geriatric Medicine Market Size (2015-2020)
• 7.2 Geriatric Medicine Key Players in Europe (2019-2020)
• 7.3 Europe Geriatric Medicine Market Size by Type (2015-2020)
• 7.4 Europe Geriatric Medicine Market Size by Application (2015-2020)

8 China

• 8.1 China Geriatric Medicine Market Size (2015-2020)
• 8.2 Geriatric Medicine Key Players in China (2019-2020)
• 8.3 China Geriatric Medicine Market Size by Type (2015-2020)
• 8.4 China Geriatric Medicine Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Geriatric Medicine Market Size (2015-2020)
• 9.2 Geriatric Medicine Key Players in Japan (2019-2020)
• 9.3 Japan Geriatric Medicine Market Size by Type (2015-2020)
• 9.4 Japan Geriatric Medicine Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Geriatric Medicine Market Size (2015-2020)
• 10.2 Geriatric Medicine Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Geriatric Medicine Market Size by Type (2015-2020)
• 10.4 Southeast Asia Geriatric Medicine Market Size by Application (2015-2020)

11 India

• 11.1 India Geriatric Medicine Market Size (2015-2020)
• 11.2 Geriatric Medicine Key Players in India (2019-2020)
• 11.3 India Geriatric Medicine Market Size by Type (2015-2020)
• 11.4 India Geriatric Medicine Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Geriatric Medicine Market Size (2015-2020)
• 12.2 Geriatric Medicine Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Geriatric Medicine Market Size by Type (2015-2020)
• 12.4 Central & South America Geriatric Medicine Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 GSK
  • 13.1.1 GSK Company Details
  • 13.1.2 GSK Business Overview
  • 13.1.3 GSK Geriatric Medicine Introduction
  • 13.1.4 GSK Revenue in Geriatric Medicine Business (2015-2020))
  • 13.1.5 GSK Recent Development
• 13.2 Boehringer Ingelheim
  • 13.2.1 Boehringer Ingelheim Company Details
  • 13.2.2 Boehringer Ingelheim Business Overview
  • 13.2.3 Boehringer Ingelheim Geriatric Medicine Introduction
  • 13.2.4 Boehringer Ingelheim Revenue in Geriatric Medicine Business (2015-2020)
  • 13.2.5 Boehringer Ingelheim Recent Development
• 13.3 Novartis
  • 13.3.1 Novartis Company Details
  • 13.3.2 Novartis Business Overview
  • 13.3.3 Novartis Geriatric Medicine Introduction
  • 13.3.4 Novartis Revenue in Geriatric Medicine Business (2015-2020)
  • 13.3.5 Novartis Recent Development
• 13.4 Bristol-Myers Squibb
  • 13.4.1 Bristol-Myers Squibb Company Details
  • 13.4.2 Bristol-Myers Squibb Business Overview
  • 13.4.3 Bristol-Myers Squibb Geriatric Medicine Introduction
  • 13.4.4 Bristol-Myers Squibb Revenue in Geriatric Medicine Business (2015-2020)
  • 13.4.5 Bristol-Myers Squibb Recent Development
• 13.5 Pfizer
  • 13.5.1 Pfizer Company Details
  • 13.5.2 Pfizer Business Overview
  • 13.5.3 Pfizer Geriatric Medicine Introduction
  • 13.5.4 Pfizer Revenue in Geriatric Medicine Business (2015-2020)
  • 13.5.5 Pfizer Recent Development
• 13.6 Eli Lilly
  • 13.6.1 Eli Lilly Company Details
  • 13.6.2 Eli Lilly Business Overview
  • 13.6.3 Eli Lilly Geriatric Medicine Introduction
  • 13.6.4 Eli Lilly Revenue in Geriatric Medicine Business (2015-2020)
  • 13.6.5 Eli Lilly Recent Development
• 13.7 Abbott
  • 13.7.1 Abbott Company Details
  • 13.7.2 Abbott Business Overview
  • 13.7.3 Abbott Geriatric Medicine Introduction
  • 13.7.4 Abbott Revenue in Geriatric Medicine Business (2015-2020)
  • 13.7.5 Abbott Recent Development
• 13.8 AstraZeneca
  • 13.8.1 AstraZeneca Company Details
  • 13.8.2 AstraZeneca Business Overview
  • 13.8.3 AstraZeneca Geriatric Medicine Introduction
  • 13.8.4 AstraZeneca Revenue in Geriatric Medicine Business (2015-2020)
  • 13.8.5 AstraZeneca Recent Development
• 13.9 Merck
  • 13.9.1 Merck Company Details
  • 13.9.2 Merck Business Overview
  • 13.9.3 Merck Geriatric Medicine Introduction
  • 13.9.4 Merck Revenue in Geriatric Medicine Business (2015-2020)
  • 13.9.5 Merck Recent Development
• 13.10 Sanofi S.A.
  • 13.10.1 Sanofi S.A. Company Details
  • 13.10.2 Sanofi S.A. Business Overview
  • 13.10.3 Sanofi S.A. Geriatric Medicine Introduction
  • 13.10.4 Sanofi S.A. Revenue in Geriatric Medicine Business (2015-2020)
  • 13.10.5 Sanofi S.A. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer